Atlas Trials

Glycogen Storage Disease Type II-Pompe's Disease

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Glycogen Storage Disease Type II-Pompe's Disease

RecordFirmDate
A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa (NCT03019406)Genzyme, a Sanofi Company2017-10-12
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease (NCT02782741)Genzyme, a Sanofi Company2016-11-02

Track Glycogen Storage Disease Type II-Pompe's Disease automatically

Every clearance here is in the API, with alerts when new ones post.